Dangerous Birth Control Drugs
Yaz - Yasmin - Ocella
At Gatti, Keltner, Bienvnu & Montesi, we are actively working on personal injury and wrongful death cases of young women who took Yasmin or Yaz at sometime during the period from 2001, when Yasmin was first launched onto the market, through 2008.
The injuries at issue vary from sudden cardiac deaths, to gallbladder and kidney problems, to thromboembolic events, such as strokes, pulmonary emboli and deep vein thrombosis. If you have experienced one or more of these conditions, or a loved one has died from them, please contact us for a free consultation to explore your legal options.
How Yaz and Yasmin Differ From Other Birth Control Drugs
Yaz and Yasmin are different from other hormonal birth control because they contain a fourth generation progestin called drospirenone. Yasmin was approved by the FDA in 2001. It is a combination of drospirenone, and ethinyl estradiol ("EE"), the estrogen. Yaz received FDA approval first in 2006, and is essentially the same, but has a slightly smaller amount of EE. Yaz and Yasmin contain the same estrogen component that has been used in low dose birth control pills since the 1960's. However, drospirenone is a new type of progestin that had never been used in the U.S. before.
How the Injuries Happen
Drospirenone causes an increase in potassium levels in the blood, which can lead to a condition known as hyperkalemia if the potassium levels get too high. Hyperkalemia can cause electrical disturbances in the heart rhythm, and can be fatal by causing sudden cardiac death, or by causing a severe thrombotic stroke. The hyperkalemia can also cause rhythm disturbances which contribute to the formation of blood clots, a problem already identified as an increased risk with the use of EE. Since Yaz and Yasmin have been on the market, there have been more than 500 adverse events reported associated with the use of these drugs; and more than 65 deaths of young women have been associated with the use of Yasmin alone since 2004. Some deaths occurred in women as young as 17.
Serious Side Effects
The drospirenone in Yaz and Yasmin also acts as a significant diuretic, which is not a health risk associated with other hormonal birth control – and not clearly warned about. As a result, these products are associated with an increased risk in gallbladder problems, kidney problems, and rhabdomyolysis in young women.
Bayer has overpromoted Yaz and Yasmin, and at the same time downplayed the risks associated with these products, including their serious side effects.
If you feel you have been injured by dangerous birth control drugs, or a loved one has suffered a wrongful death, contact Gatti, Keltner, Bienvenu & Montesi for a free consultation to discuss how to hold the drug makers accountable.